Lsv Asset Management’s Biogen Inc Position
Does Lsv Asset Management own Biogen Inc (BIIB)? Yes — 333.7K shares worth $61M (+0.13% of its 13F portfolio) as of Q1 2026, up from 316.8K shares the prior filed quarter.
Position Value
$61M
Q1 2026
Shares
333.7K
% of Portfolio
+0.13%
Quarters Held
28
currently held
Position History BIIB
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 333.7K | $61M | +0.13% |
| Q4 2025 | 316.8K | $56M | +0.12% |
| Q3 2025 | 306.8K | $43M | +0.09% |
| Q2 2025 | 252.0K | $32M | +0.07% |
| Q1 2025 | 242.0K | $33M | +0.08% |
| Q4 2024 | 234.4K | $36M | +0.08% |
| Q3 2024 | 41.5K | $8M | +0.02% |
| Q4 2023 | 117.0K | $30M | +0.07% |
| Q3 2023 | 344.7K | $89M | +0.21% |
| Q2 2023 | 353.4K | $101M | +0.22% |
| Q1 2023 | 366.5K | $102M | +0.23% |
| Q4 2022 | 358.9K | $99M | +0.22% |
| Q3 2022 | 369.1K | $99M | +0.23% |
| Q2 2022 | 370.5K | $76M | +0.16% |
| Q1 2022 | 373.6K | $79M | +0.14% |
| Q4 2021 | 355.0K | $85M | +0.15% |
| Q3 2021 | 361.6K | $102M | +0.18% |
| Q2 2021 | 360.2K | $125M | +0.21% |
| Q1 2021 | 918.1K | $257M | +0.44% |
| Q4 2020 | 938.3K | $230M | +0.42% |
| Q3 2020 | 989.1K | $281M | +0.57% |
| Q2 2020 | 1.01M | $270M | +0.56% |
| Q1 2020 | 1.07M | $340M | +0.82% |
| Q4 2019 | 1.12M | $332M | +0.52% |
| Q3 2019 | 1.12M | $260M | +0.43% |
| Q2 2019 | 1.07M | $250M | +0.40% |
| Q1 2019 | 922.9K | $218M | +0.35% |
| Q4 2018 | 780.5K | $235M | +0.42% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of BIIB.